149 related articles for article (PubMed ID: 31384126)
1. A Comparison of Death Domain-Associated Protein 6 in Different Endometrial Carcinomas Histotypes.
Jin C; Hacking S; Komforti MK; Nasim M
Biomark Insights; 2019; 14():1177271919864892. PubMed ID: 31384126
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
Dyhdalo KS; Ababneh E; Lanigan C; Bowers K; Zhang S; McKenney JK; Joehlin-Price AS
Int J Gynecol Pathol; 2023 Sep; 42(5):443-450. PubMed ID: 36731037
[TBL] [Abstract][Full Text] [Related]
3. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
Schlosshauer PW; Ellenson LH; Soslow RA
Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
[TBL] [Abstract][Full Text] [Related]
5. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.
Wang Y; Tao VL; Shin CY; Salamanca C; Chen SY; Chow C; Köbel M; Ben-Neriah S; Farnell D; Steidl C; Mcalpine JN; Gilks CB; Huntsman DG
PLoS One; 2020; 15(10):e0240412. PubMed ID: 33052929
[TBL] [Abstract][Full Text] [Related]
7. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas.
Tessier-Cloutier B; Soslow RA; Stewart CJR; Köbel M; Lee CH
Histopathology; 2018 Aug; 73(2):299-305. PubMed ID: 29671892
[TBL] [Abstract][Full Text] [Related]
9. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.
Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA
Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification.
Santoro A; Angelico G; Travaglino A; Raffone A; Arciuolo D; D'Alessandris N; Inzani F; Zannoni GF
Gynecol Oncol; 2021 May; 161(2):629-635. PubMed ID: 33712277
[TBL] [Abstract][Full Text] [Related]
11. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.
Lax SF; Kurman RJ; Pizer ES; Wu L; Ronnett BM
Am J Surg Pathol; 2000 Sep; 24(9):1201-8. PubMed ID: 10976693
[TBL] [Abstract][Full Text] [Related]
12. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
13. SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.
Tessier-Cloutier B; Coatham M; Carey M; Nelson GS; Hamilton S; Lum A; Soslow RA; Stewart CJ; Postovit LM; Köbel M; Lee CH
J Pathol Clin Res; 2021 Mar; 7(2):144-153. PubMed ID: 33125840
[TBL] [Abstract][Full Text] [Related]
14. Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.
Kang EY; Tessier-Cloutier B; Duggan MA; Stewart CJR; Lee CH; Köbel M
Histopathology; 2021 Aug; 79(2):160-167. PubMed ID: 33432679
[TBL] [Abstract][Full Text] [Related]
15. Interobserver Variability in the Diagnosis of Uterine High-Grade Endometrioid Carcinoma.
Thomas S; Hussein Y; Bandyopadhyay S; Cote M; Hassan O; Abdulfatah E; Alosh B; Guan H; Soslow RA; Ali-Fehmi R
Arch Pathol Lab Med; 2016 Aug; 140(8):836-43. PubMed ID: 27139150
[TBL] [Abstract][Full Text] [Related]
16. Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.
Espinosa I; De Leo A; D'Angelo E; Rosa-Rosa JM; Corominas M; Gonzalez A; Palacios J; Prat J
Hum Pathol; 2018 Feb; 72():100-106. PubMed ID: 29133142
[TBL] [Abstract][Full Text] [Related]
17. Prognostic importance of DNA ploidy in non-endometrioid, high-risk endometrial carcinomas.
Sorbe B
Oncol Lett; 2016 Mar; 11(3):2283-2289. PubMed ID: 26998163
[TBL] [Abstract][Full Text] [Related]
18. Role of Immunohistochemistry to Distinguish Grade 3 Endometrioid Carcinoma and Uterine Serous Carcinoma.
Zaidi A; Gupta P; Gupta N; Rajwanshi A; Rai B; Gainder S
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):42-48. PubMed ID: 31815745
[TBL] [Abstract][Full Text] [Related]
19. A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system.
Kim HJ; Kim TJ; Lee YY; Choi CH; Lee JW; Bae DS; Kim BG
J Gynecol Oncol; 2013 Apr; 24(2):120-7. PubMed ID: 23653828
[TBL] [Abstract][Full Text] [Related]
20. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]